Coenzyme M (commonly known by its salt form, Mesna) is a synthetic sulfhydryl (thiol) compound and is used for prophylaxis of Ifosfamide and cyclophosphamide induced hemorrhagic cystitis.
Mesna is a uroprotective agent and is used prophylactically to reduce ifosfamide and cyclophosphamide induced hemorrhagic cystitis.
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Huntington, West Virginia, United States
Medical Research Council Clinical Trials Unit, London, England, United Kingdom
The Methodist Hospital, Houston, Texas, United States
The Methodist Hospital, Houston, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
All Children's Hospital, St. Petersburg, Florida, United States
Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States
Children's Hospital Central California, Madera, California, United States
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Advocate Christ Medical Center, Oak Lawn, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.